We also observed that production of TNFα by PBMCs tended to be higher in response to the cell-free fecal slurry of treatment-naïve pediatric CD patients than HC subjects, and that this immunogenicity decreased during treatment with EEN and returned to similar levels as seen in HC subjects. The gene discussed is TNF; the disease is Cowden disease.